U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Approval Year

1991
122
Substance Class Protein
Created
by admin
on Wed Apr 02 08:31:43 GMT 2025
Edited
by admin
on Wed Apr 02 08:31:43 GMT 2025
Protein Sub Type
Sequence Type COMPLETE
Record UNII
T0LTO7L82X
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ANTITHROMBIN III (HUMAN)
Preferred Name English
ANTITHROMBIN III HUMAN
USP   USP-RS  
Common Name English
ANTITHROMBIN III [VANDF]
Common Name English
ANTITHROMBIN III
INN   MART.   VANDF   WHO-DD  
INN  
Official Name English
ANTITHROMBIN III HUMAN [USP MONOGRAPH]
Common Name English
antithrombin iii [INN]
Common Name English
Antithrombin iii [WHO-DD]
Common Name English
HEPARIN COFACTOR B
Common Name English
ANTITHROMBIN III, HUMAN
Common Name English
ANTITHROMBIN
Common Name English
ANTITHROMBIN III HUMAN [USP-RS]
Common Name English
KYBERNIN P
Brand Name English
ANTITHROMBIN III,HUMAN
VANDF  
Common Name English
KYBERNIN
Brand Name English
ANTITHROMBIN III,HUMAN [VANDF]
Common Name English
ANTITHROMBIN III [MART.]
Common Name English
ANTITHROMBIN III HUMAN PLASMA-DERIVED
Common Name English
ANTITHROMBIN III (HUMAN) CONCENTRATE IV
Common Name English
THROMBATE III
Brand Name English
ATNATIV
Brand Name English
AT-III
Common Name English
ORG 10849
Code English
ATENATIV
Brand Name English
Classification Tree Code System Code
LOINC 91120-6
Created by admin on Wed Apr 02 08:31:43 GMT 2025 , Edited by admin on Wed Apr 02 08:31:43 GMT 2025
LOINC 20991-6
Created by admin on Wed Apr 02 08:31:43 GMT 2025 , Edited by admin on Wed Apr 02 08:31:43 GMT 2025
LOINC 3174-0
Created by admin on Wed Apr 02 08:31:43 GMT 2025 , Edited by admin on Wed Apr 02 08:31:43 GMT 2025
FDA ORPHAN DRUG 11485
Created by admin on Wed Apr 02 08:31:43 GMT 2025 , Edited by admin on Wed Apr 02 08:31:43 GMT 2025
WHO-ATC B01AB02
Created by admin on Wed Apr 02 08:31:43 GMT 2025 , Edited by admin on Wed Apr 02 08:31:43 GMT 2025
FDA ORPHAN DRUG 7185
Created by admin on Wed Apr 02 08:31:43 GMT 2025 , Edited by admin on Wed Apr 02 08:31:43 GMT 2025
WHO-VATC QB01AB02
Created by admin on Wed Apr 02 08:31:43 GMT 2025 , Edited by admin on Wed Apr 02 08:31:43 GMT 2025
FDA ORPHAN DRUG 5084
Created by admin on Wed Apr 02 08:31:43 GMT 2025 , Edited by admin on Wed Apr 02 08:31:43 GMT 2025
LOINC 3176-5
Created by admin on Wed Apr 02 08:31:43 GMT 2025 , Edited by admin on Wed Apr 02 08:31:43 GMT 2025
FDA ORPHAN DRUG 4084
Created by admin on Wed Apr 02 08:31:43 GMT 2025 , Edited by admin on Wed Apr 02 08:31:43 GMT 2025
Code System Code Type Description
RXCUI
1009
Created by admin on Wed Apr 02 08:31:43 GMT 2025 , Edited by admin on Wed Apr 02 08:31:43 GMT 2025
ALTERNATIVE
RXCUI
221062
Created by admin on Wed Apr 02 08:31:43 GMT 2025 , Edited by admin on Wed Apr 02 08:31:43 GMT 2025
PRIMARY
ECHA (EC/EINECS)
232-568-2
Created by admin on Wed Apr 02 08:31:43 GMT 2025 , Edited by admin on Wed Apr 02 08:31:43 GMT 2025
PRIMARY
EVMPD
SUB127274
Created by admin on Wed Apr 02 08:31:43 GMT 2025 , Edited by admin on Wed Apr 02 08:31:43 GMT 2025
PRIMARY
INN
6368
Created by admin on Wed Apr 02 08:31:43 GMT 2025 , Edited by admin on Wed Apr 02 08:31:43 GMT 2025
PRIMARY
EVMPD
SUB12917MIG
Created by admin on Wed Apr 02 08:31:43 GMT 2025 , Edited by admin on Wed Apr 02 08:31:43 GMT 2025
PRIMARY
DAILYMED
T0LTO7L82X
Created by admin on Wed Apr 02 08:31:43 GMT 2025 , Edited by admin on Wed Apr 02 08:31:43 GMT 2025
PRIMARY
ChEMBL
CHEMBL2108849
Created by admin on Wed Apr 02 08:31:43 GMT 2025 , Edited by admin on Wed Apr 02 08:31:43 GMT 2025
PRIMARY
FDA UNII
T0LTO7L82X
Created by admin on Wed Apr 02 08:31:43 GMT 2025 , Edited by admin on Wed Apr 02 08:31:43 GMT 2025
PRIMARY
MESH
D000990
Created by admin on Wed Apr 02 08:31:43 GMT 2025 , Edited by admin on Wed Apr 02 08:31:43 GMT 2025
PRIMARY
NCI_THESAURUS
C136824
Created by admin on Wed Apr 02 08:31:43 GMT 2025 , Edited by admin on Wed Apr 02 08:31:43 GMT 2025
PRIMARY
ChEMBL
CHEMBL2108574
Created by admin on Wed Apr 02 08:31:43 GMT 2025 , Edited by admin on Wed Apr 02 08:31:43 GMT 2025
PRIMARY
SMS_ID
100000089108
Created by admin on Wed Apr 02 08:31:43 GMT 2025 , Edited by admin on Wed Apr 02 08:31:43 GMT 2025
PRIMARY
RS_ITEM_NUM
1040504
Created by admin on Wed Apr 02 08:31:43 GMT 2025 , Edited by admin on Wed Apr 02 08:31:43 GMT 2025
PRIMARY
CAS
9000-94-6
Created by admin on Wed Apr 02 08:31:43 GMT 2025 , Edited by admin on Wed Apr 02 08:31:43 GMT 2025
PRIMARY
DRUG BANK
DB11598
Created by admin on Wed Apr 02 08:31:43 GMT 2025 , Edited by admin on Wed Apr 02 08:31:43 GMT 2025
PRIMARY
From To
1_8 1_128
1_21 1_95
1_247 1_430
Glycosylation Type HUMAN
Glycosylation Link Type Site
N 1_96
N 1_135
N 1_155
N 1_192
Related Record Type Details
Structure of FONDAPARINUX
BINDER->LIGAND
BINDING
Related Record Type Details
ANTITHROMBIN III HUMAN
ACTIVE MOIETY

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
AMINO_ACID_SUBSTITUTION [1_36] DEXFOSFOSERINE VI4F0K069V
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966